SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-21-251551
Filing Date
2021-08-19
Accepted
2021-08-19 16:28:03
Documents
53
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 6-K d179836d6k.htm 6-K 14809
2 EX-99.1 d179836dex991.htm EX-99.1 231694
3 EX-99.2 d179836dex992.htm EX-99.2 100025
4 EX-99.3 d179836dex993.htm EX-99.3 492962
5 EX-99.4 d179836dex994.htm EX-99.4 97807
  Complete submission text file 0001193125-21-251551.txt   2845072

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ncna-20210630.xml EX-101.INS 457264
7 XBRL TAXONOMY EXTENSION SCHEMA ncna-20210630.xsd EX-101.SCH 28710
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ncna-20210630_cal.xml EX-101.CAL 32197
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ncna-20210630_def.xml EX-101.DEF 69410
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ncna-20210630_lab.xml EX-101.LAB 196142
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ncna-20210630_pre.xml EX-101.PRE 153081
Mailing Address 3 LOCHSIDE WAY EDINBURGH X0 EH12 9DT
Business Address 3 LOCHSIDE WAY EDINBURGH X0 EH12 9DT 44-0-131-357-1111
NuCana plc (Filer) CIK: 0001709626 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38215 | Film No.: 211190410
SIC: 2834 Pharmaceutical Preparations